United-Guardian Inc. Q2 2025 Results: Net Sales Drop 16.3%, Net Income Falls 34.5%, EPS Down to $0.14

Reuters
Aug 08
United-Guardian Inc. <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results: Net Sales Drop 16.3%, Net Income Falls 34.5%, EPS Down to $0.14

United-Guardian, Inc. $(UG)$ has announced its financial results for the second quarter and the first half of 2025. The company's second quarter net sales decreased to $2.84 million, down from $3.39 million in the same period of 2024. Net income for the quarter also fell to $626,826, compared to $956,225 in the second quarter of 2024. This represents a decrease in earnings per share from $0.21 to $0.14. However, when compared to the first quarter of 2025, the second quarter showed a 14% increase in net sales and a 12% increase in net income. For the six-month period ending June 30, 2025, net sales were $5.32 million, a decrease from $6.65 million in the same period in 2024. Net income for the first half of 2025 was $1.19 million, down from $1.88 million in the first half of the previous year, with earnings per share declining from $0.41 to $0.26. Donna Vigilante, President of United-Guardian, highlighted the increase in sales of pharmaceuticals and medical lubricants during the first half of 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United-Guardian Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-005206), on August 08, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10